Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.
More than 35 million people worldwide had dementia in 2010 and this number is expected to exceed 115 million by 2050. This paper reports on the opportunities offered by the informatics revolution and big data to address Alzheimer’s Disease and dementia. This will require careful planning and multi-stakeholder collaboration as technical, administrative, regulatory, infrastructure and financial obstacles emerge.
This report presents new evidence on how governments steer and fund public research in higher education and public research institutions through research excellence initiatives (REIs). It provides information on how REIs work and institutions that host centres of excellence. The findings show some of the benefits to be gained through REIs and pitfalls to be avoided.
An ageing population brings new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases.
This report describes recent trends in government and institutional level policies to enhance the transfer and exploitation of public research. It also benchmarks a set of countries, universities and public research institutions based on both traditional and new indicators.
This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.
Young firms play a crucial role in job creation but have missed out on many of the benefits of structural reforms of the past decade in OECD countries.
Most OECD governments use tax incentives to encourage businesses to invest in research and development (R&D) to boost innovation and drive economic growth. Others, like China, India and South Africa, are doing the same. But reforming these incentives would give countries a better return on their investment and support young innovative firms that play a crucial role in job creation, according to a new OECD report.
The OECD has recommended its Member Countries apply existing international and national chemical regulatory frameworks to manage the risks associated with manufactured nanomaterials.